NCT00594815View on ClinicalTrials.gov

Combined Immunochemotherapy Followed By Reduced Dose Radiation Therapy (RT) for Patients With Newly Diagnosed Primary Central Nervous System Lymphoma

NACompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

August 28, 2002

Primary Completion Date

February 23, 2016

Study Completion Date

February 23, 2016

Conditions
Lymphoma
Interventions
DRUG

Cytarabine, Leucovorin, Methotrexate, Procarbazine, Rituximab, Vincristine

Immunochemotherapy

Trial Locations (1)

10065

Memorial Sloan Kettering Cancer Center, New York

All Listed Sponsors
collaborator

Northwestern Memorial Hospital

OTHER

collaborator

Columbia University

OTHER

collaborator

Kentuckiana Cancer Institute

OTHER

collaborator

University of Virginia

OTHER

collaborator

University of Vermont

OTHER

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00594815 - Combined Immunochemotherapy Followed By Reduced Dose Radiation Therapy (RT) for Patients With Newly Diagnosed Primary Central Nervous System Lymphoma | Biotech Hunter | Biotech Hunter